Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation

Summary by Intelligence360 News
Open the article to view the coverage from Intelligence360 News
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

2 Articles

Intelligence360 NewsIntelligence360 News

Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation

Open the article to view the coverage from Intelligence360 News

Read Full Article
bionity.combionity.com

Cellares Aims to Industrialize Global Cell Therapy Production Through Groundbreaking Automation.

Cellares, the first integrated development and production organization (IDMO), announced a $257 million Series D financing round led by investment funds led by BlackRock and Eclipse, bringing the company's total funding to $612 million.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

bionity.com broke the news in on Tuesday, February 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

BlackRock icon

BlackRock

Germany icon

Germany

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal